Abstract:Abstract One of the main problems with the joint use of multiple drugs is that it may cause adverse drug interactions and side effects that damage the body. Therefore, it is important to predict potential drug interactions. However, most of the available prediction methods can only predict whether two drugs interact or not, whereas few methods can predict interaction events between two drugs. Accurately predicting interaction events of two drugs is more useful for researchers to study the mechanism of the interaction of two drugs. In the present study, we propose a novel method, MDF-SA-DDI, which predicts drug–drug interaction (DDI) events based on multi-source drug fusion, multi-source feature fusion and transformer self-attention mechanism. MDF-SA-DDI is mainly composed of two parts: multi-source drug fusion and multi-source feature fusion. First, we combine two drugs in four different ways and input the combined drug feature representation into four different drug fusion networks (Siamese network, convolutional neural network and two auto-encoders) to obtain the latent feature vectors of the drug pairs, in which the two auto-encoders have the same structure, and their main difference is the number of neurons in the input layer of the two auto-encoders. Then, we use transformer blocks that include self-attention mechanism to perform latent feature fusion. We conducted experiments on three different tasks with two datasets. On the small dataset, the area under the precision–recall-curve (AUPR) and F1 scores of our method on task 1 reached 0.9737 and 0.8878, respectively, which were better than the state-of-the-art method. On the large dataset, the AUPR and F1 scores of our method on task 1 reached 0.9773 and 0.9117, respectively. In task 2 and task 3 of two datasets, our method also achieved the same or better performance as the state-of-the-art method. More importantly, the case studies on five DDI events are conducted and achieved satisfactory performance. The source codes and data are available at https://github.com/ShenggengLin/MDF-SA-DDI.

deepMDDI: A deep graph convolutional network framework for multi-label prediction of drug-drug interactions

MTDDI: a Graph Convolutional Network Framework for Predicting Multi-Type Drug-Drug Interactions

MASMDDI: multi-layer adaptive soft-mask graph neural network for drug-drug interaction prediction

MCFF-MTDDI: multi-channel feature fusion for multi-typed drug–drug interaction prediction

DPDDI: a deep predictor for drug-drug interactions

A Multimodal Deep Learning Framework for Predicting Drug-Drug Interaction Events.

Interpretable multi-view attention network for drug-drug interaction prediction.

Predicting drug-drug interactions using multi-modal deep auto-encoders based network embedding and positive-unlabeled learning

Multitype drug interaction prediction based on the deep fusion of drug features and topological relationships

Structural Network Embedding Using Multi-modal Deep Auto-encoders for Predicting Drug-drug Interactions

DGANDDI: Double Generative Adversarial Networks for Drug-Drug Interaction Prediction

Deep learning for drug‐drug interaction prediction: A comprehensive review

MGDDI: A multi-scale graph neural networks for drug-drug interaction prediction

Geometric molecular graph representation learning model for drug-drug interactions prediction

TP-DDI: A Two-Pathway Deep Neural Network for Drug–Drug Interaction Prediction

AMDE: a novel attention-mechanism-based multidimensional feature encoder for drug–drug interaction prediction

MPCDDI: A Secure Multiparty Computation-Based Deep Learning Framework for Drug-Drug Interaction Predictions

MDF-SA-DDI: predicting drug–drug interaction events based on multi-source drug fusion, multi-source feature fusion and transformer self-attention mechanism

An effective framework for predicting drug–drug interactions based on molecular substructures and knowledge graph neural network

MDNN: A Multimodal Deep Neural Network for Predicting Drug-Drug Interaction Events

DeepDrug: A General Graph-Based Deep Learning Framework for Drug-Drug Interactions and Drug-Target Interactions Prediction